The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS
Debora Soncini(University of Genoa), Michele Cea(Azienda Ospedaliera S.Maria), Santina Bruzzone(University of Genoa), Aimable Nahimana(University of Lausanne), Pamela Becherini(Ospedale Policlinico San Martino), Claudia Martinuzzi(Ospedale Policlinico San Martino), Silvia Ravera(Ospedale Policlinico San Martino), Francesco Piacente(University of Genoa), Giulia Giorgetti(Dana-Farber Cancer Institute), Francesco Ladisa(Dana-Farber Cancer Institute), Alessio Nencioni(Ospedale Policlinico San Martino), Michel A. Duchosal(Scripps Health), Roberto M. Lemoli(University of Genoa)
Cited by 0
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Slc12a8 is a nicotinamide mononucleotide transporter
|Nature Metabolism|2018|279
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|192
The Na<sup>+</sup>-P<sub>i</sub>cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary P<sub>i</sub>
|American Journal of Physiology-Renal Physiology|2008|172